(Q28195426)

English

Small molecule glycoprotein IIb/IIIa receptor inhibitors as upstream therapy in acute coronary syndromes: insights from the TACTICS TIMI-18 trial

scientific article (publication date: 19 February 2003)

In more languages

Statements

scholarly article

0 references

1 reference

Europe PubMed Central

Small molecule glycoprotein IIb/IIIa receptor inhibitors as upstream therapy in acute coronary syndromes: insights from the TACTICS TIMI-18 trial (English)

0 references

acute coronary syndrome

1 reference

based on heuristic

inferred from title

author name string

Christopher P Cannon

1

0 references

language of work or name

0 references

publication date

19 February 2003

0 references

Journal of the American College of Cardiology

0 references

41

0 references

4 Suppl S

0 references

43S-48S

0 references

A comparison of aspirin plus tirofiban with aspirin plus heparin for unstable angina

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2903018-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Inhibition of the platelet glycoprotein IIb/IIIa receptor with tirofiban in unstable angina and non-Q-wave myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2903018-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Inhibition of platelet glycoprotein IIb/IIIa with eptifibatide in patients with acute coronary syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2903018-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Platelet GPIIb-IIIa blockers

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2903018-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical outcomes of therapeutic agents that block the platelet glycoprotein IIb/IIIa integrin in ischemic heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2903018-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Platelet glycoprotein IIb/IIIa receptor inhibition in non-ST-elevation acute coronary syndromes: early benefit during medical treatment only, with additional protection during percutaneous coronary intervention

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2903018-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of glycoprotein IIb/IIIa receptor blocker abciximab on outcome in patients with acute coronary syndromes without early coronary revascularisation: the GUSTO IV-ACS randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2903018-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Attainment and maintenance of platelet inhibition through standard dosing of abciximab in diabetic and nondiabetic patients undergoing percutaneous coronary intervention

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2903018-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacodynamics and pharmacokinetics of eptifibatide in patients with acute coronary syndromes: prospective analysis from PURSUIT.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2903018-8

7 January 2021

based on heuristic

inferred from DOI database lookup

ACC/AHA Guideline Update for the Management of Patients With Unstable Angina and Non-ST-Segment Elevation Myocardial Infarction--2002: Summary Article: A Report of the American College of Cardiology/American Heart Association Task Force on Practice G

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2903018-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Benefit of abciximab in patients with refractory unstable angina in relation to serum troponin T levels. c7E3 Fab Antiplatelet Therapy in Unstable Refractory Angina (CAPTURE) Study Investigators.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2903018-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Troponin concentrations for stratification of patients with acute coronary syndromes in relation to therapeutic efficacy of tirofiban. PRISM Study Investigators. Platelet Receptor Inhibition in Ischemic Syndrome Management

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2903018-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Benefit of glycoprotein IIb/IIIa inhibition in patients with acute coronary syndromes and troponin t-positive status: the paragon-B troponin T substudy

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2903018-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Elevation in serum troponin I predicts the benefit of tirofiban

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2903018-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Platelet glycoprotein IIb/IIIa inhibitors reduce mortality in diabetic patients with non-ST-segment-elevation acute coronary syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2903018-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Reduction of recurrent ischemia with abciximab during continuous ECG-ischemia monitoring in patients with unstable angina refractory to standard treatment (CAPTURE)

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2903018-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Prior aspirin use predicts worse outcomes in patients with non-ST-elevation acute coronary syndromes. PURSUIT Investigators. Platelet IIb/IIIa in Unstable angina: Receptor Suppression Using Integrilin Therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2903018-8

7 January 2021

based on heuristic

inferred from DOI database lookup

An integrated clinical approach to predicting the benefit of tirofiban in non-ST elevation acute coronary syndromes. Application of the TIMI Risk Score for UA/NSTEMI in PRISM-PLUS

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2903018-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Angiographic findings in patients with refractory unstable angina according to troponin T status

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2903018-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Elevations in troponin T and I are associated with abnormal tissue level perfusion: a TACTICS-TIMI 18 substudy. Treat Angina with Aggrastat and Determine Cost of Therapy with an Invasive or Conservative Strategy-Thrombolysis in Myocardial Infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2903018-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Assessment of coronary angiograms prior to and after treatment with abciximab, and the outcome of angioplasty in refractory unstable angina patients. Angiographic results from the CAPTURE trial

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2903018-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Intracoronary thrombus and platelet glycoprotein IIb/IIIa receptor blockade with tirofiban in unstable angina or non-Q-wave myocardial infarction. Angiographic results from the PRISM-PLUS trial (Platelet receptor inhibition for ischemic syndrome man

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2903018-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Q-wave myocardial infarction. Results of the TIMI IIIB Trial. Thrombolysis in Myocardial Ischemia

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2903018-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2903018-8

7 January 2021

based on heuristic

inferred from DOI database lookup

One-year results of the Thrombolysis in Myocardial Infarction (TIMI) IIIB clinical trial. A randomized comparison of tissue-type plasminogen activator versus placebo and early invasive versus early conservative strategies in unstable angina and non-

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2903018-8

7 January 2021

based on heuristic

inferred from DOI database lookup

A prospective randomized trial of triage angiography in acute coronary syndromes ineligible for thrombolytic therapy. Results of the medicine versus angiography in thrombolytic exclusion (MATE) trial

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2903018-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Outcomes in patients with acute non-Q-wave myocardial infarction randomly assigned to an invasive as compared with a conservative management strategy. Veterans Affairs Non-Q-Wave Infarction Strategies in Hospital (VANQWISH) Trial Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2903018-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Outcome at 1 year after an invasive compared with a non-invasive strategy in unstable coronary-artery disease: the FRISC II invasive randomised trial. FRISC II Investigators. Fast Revascularisation during Instability in Coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2903018-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Ability of minor elevations of troponins I and T to predict benefit from an early invasive strategy in patients with unstable angina and non-ST elevation myocardial infarction: results from a randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2903018-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Enoxaparin prevents death and cardiac ischemic events in unstable angina/non-Q-wave myocardial infarction. Results of the thrombolysis in myocardial infarction (TIMI) 11B trial

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2903018-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Trial of invasive versus medical therapy in elderly patients with chronic symptomatic coronary-artery disease (TIME): a randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2903018-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Danish multicenter randomized study of invasive versus conservative treatment in patients with inducible ischemia after thrombolysis in acute myocardial infarction (DANAMI). DANish trial in Acute Myocardial Infarction.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2903018-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Value of first day angiography/angioplasty in evolving Non-ST segment elevation myocardial infarction: an open multicenter randomized trial. The VINO Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2903018-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Interventional versus conservative treatment for patients with unstable angina or non-ST-elevation myocardial infarction: the British Heart Foundation RITA 3 randomised trial. Randomized Intervention Trial of unstable Angina

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2903018-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Reappraising the role of immediate intervention following thrombolytic recanalization in acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2903018-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Use of risk stratification to identify patients with unstable angina likeliest to benefit from an invasive versus conservative management strategy

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2903018-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of refractory unstable angina in geographically isolated areas without cardiac surgery. Invasive versus conservative strategy (TRUCS study)

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2903018-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0735-1097(02)03018-8

0 references

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q28195426&oldid=1622312666"